(NASDAQ: NEPH) Nephros's forecast annual revenue growth rate of 9.29% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 118.2%.
Nephros's revenue in 2026 is $19,124,000.On average, 4 Wall Street analysts forecast NEPH's revenue for 2026 to be $226,901,811, with the lowest NEPH revenue forecast at $214,916,185, and the highest NEPH revenue forecast at $236,889,834.
In 2027, NEPH is forecast to generate $253,174,653 in revenue, with the lowest revenue forecast at $243,251,770 and the highest revenue forecast at $260,622,243.